Regeneron Gets PTAB To Review Syringe Patent On 2nd Go
Regeneron has convinced the Patent Trial and Appeal Board to review claims in a Novartis patent that covers a type of syringe used in eye injections after the Swiss drug giant...To view the full article, register now.
Already a subscriber? Click here to view full article